Photodynamic therapy in gastrointestinal cancer
β Scribed by Dr. Strashimir Karanov; Maria Shopova; Hristo Getov
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 407 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
β¦ Synopsis
Six patients with an early stage of gastrointestinal (GI) cancer (TINoMo, stage I) were successfully treated by photodynamic therapy (PDT) as follows: esophagus-1, stomach-2, rectum-3. The patients were photosensitized 72 hrs rior to treatment with pure venous infusion. Argon-pumped dye laser light at 0.630 pm wavelength was used in single and multiple treatment sessions with the power density ranging from 0.015 to 0.192 W.m-2 and a dose varying from 0.320 to 1.600 kJ.m-2. Tumor eradication (complete response) was obtained in each of the patients. No early or late treatment related complications were recorded. The patients were followed-up in the course of 7-16 months after treatment and no local recurrence or general development of disease (metastases) were reported. PDT in the early stage of GI carcinoma was recognized as a radical therapeutic method in clinical oncology.
π SIMILAR VOLUMES
A theory and method for prediction and measurement of the effective absorbed dose in photodynamic therapy of cancer is presented. The method depends on measuring the concentration of the photosensitizer (such as dihematorporphyrin ether), the flux density of the light, and the relative photodynamic
## Abstract ## Background and Objective Endobronchial photodynamic therapy (PDT) is a minimally invasive technique for the palliation of major airway obstruction from lung cancer, and for the treatment of endobronchial microinvasive lung cancer. ## Study Design Results of reported clinical trial